Global Veterinary Antimicrobial Susceptibility testing Market – Industry Trends and Forecast to 2030

Global Veterinary Antimicrobial Susceptibility Testing Market,  By Product Type (Disks and Plates, Culture Media, Accessories and Consumables and Automated Antimicrobial Susceptibility Testing Instruments), Animal Type (Food-producing Animals and Companion Animals), End User (Veterinary Reference Laboratory, Veterinary Research Institutes and Universities, and Other) – Industry Trends and Forecast to 2030.

Veterinary Antimicrobial Susceptibility Testing Market Analysis and Size

Increasing prevalence of antimicrobial resistance in animals have carved the way for the growth of veterinary antimicrobial susceptibility testing market. Veterinarians and animal healthcare professionals are increasingly adopting antimicrobial susceptibility testing to guide appropriate treatment decisions. Antimicrobial susceptibility testing helps in determining the most effective antimicrobial agents for treating infections in animals, ensuring that the selected drugs are likely to be effective against the specific pathogens involved.

Data Bridge Market Research analyses that the global veterinary antimicrobial susceptibility testing market which was USD 37.64 billion in 2022, would rocket up to USD 58.66 billion by 2030, and is expected to undergo a CAGR of 5.24% during the forecast period. This indicates that the discs and plates dominate the product type segment of the veterinary antimicrobial susceptibility testing market owing to the advancements in technology have led to the development of rapid and automated antimicrobial susceptibility testing methods for veterinary use. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Veterinary Antimicrobial Susceptibility Testing Market Scope and Segmentation

Market Definition

The veterinary antimicrobial susceptibility testing market refers to the segment of the healthcare industry that focuses on the testing and analysis of microorganisms, particularly bacteria, isolated from animals to determine their susceptibility or resistance to various antimicrobial agents. Antimicrobial susceptibility testing involves subjecting the isolated microorganisms to different antibiotics or antimicrobial agents to assess their effectiveness in inhibiting or killing the pathogens. The testing helps to determine the appropriate treatment options and guide veterinarians in selecting the most suitable antimicrobial agents for treating infections in animals.         

Global Veterinary Antimicrobial Susceptibility Testing Market Dynamics

Drivers

• Rising Prevalence of Antimicrobial Resistance

The increasing prevalence of antimicrobial resistance in animals is a significant driver for the veterinary antimicrobial susceptibility testing market. Antimicrobial resistance poses a threat to animal health, welfare, and the effectiveness of antimicrobial treatments. Veterinary antimicrobial susceptibility testing helps in identifying the most effective antimicrobial agents for treating infections, thereby combating the challenge of antimicrobial resistance.

• Growing Awareness of Responsible Antibiotic Use

There is a growing awareness among veterinarians, animal healthcare professionals, and pet owners about the need for responsible antibiotic use in animals. Antibiotic stewardship programs and guidelines are being implemented to promote judicious use of antibiotics and reduce the development of antimicrobial resistance. Veterinary antimicrobial susceptibility testing plays a crucial role in supporting responsible antibiotic use by providing information on the susceptibility patterns of pathogens, helping veterinarians make informed treatment decisions.

• Regulatory Initiatives and Guidelines:

Regulatory bodies and organizations have implemented regulations and guidelines to control and monitor antimicrobial use in veterinary medicine. These initiatives aim to reduce the misuse and overuse of antibiotics, limit the development of antimicrobial resistance, and ensure the safety and efficacy of antimicrobial agents. Veterinary antimicrobial susceptibility testing is an essential tool for implementing and monitoring these regulatory measures, driving the demand for testing services and products.

• Advancements in Testing Technologies

Technological advancements have led to the development of rapid, accurate, and automated testing methods for veterinary antimicrobial susceptibility testing. These advanced technologies offer quicker turnaround times, enable high-throughput testing, and provide more precise results. The availability of such advanced testing systems has increased the adoption of veterinary antimicrobial susceptibility testing, driving the market growth.

Opportunities

• Increasing Adoption of Point-of-Care Testing:

Point-of-care testing (POCT) refers to conducting diagnostic tests and obtaining results in real-time at the point of patient care. The adoption of POCT in veterinary medicine is growing, and there is an opportunity for the development of portable and easy-to-use antimicrobial susceptibility testing devices that can be used directly in veterinary clinics or on-field. These rapid testing solutions would provide immediate results, enabling prompt treatment decisions and improving patient outcomes.

• Expansion of Veterinary Reference Laboratories

Veterinary reference laboratories play a crucial role in providing specialized diagnostic services, including antimicrobial susceptibility testing, to veterinary clinics and hospitals. With the increasing demand for accurate and comprehensive diagnostic testing, there is an opportunity for the expansion of veterinary reference laboratories. These laboratories can invest in advanced testing technologies, expand their testing capacities, and offer a wide range of antimicrobial susceptibility testing services to meet the growing market needs.

Restraints

• High cost associated with veterinary antimicrobial susceptibility testing

Veterinary antimicrobial susceptibility testing can be costly, especially when advanced testing technologies and comprehensive panels of antimicrobial agents are involved. The cost of testing may pose a challenge for veterinary clinics, especially those with limited budgets or in regions with lower affordability. Cost considerations can limit the widespread adoption of antimicrobial susceptibility testing and affect the accessibility of testing services, particularly in resource-limited settings.

Challenges

• Limited Availability of Testing Services:

In certain regions, especially rural or underserved areas, there may be a limited availability of veterinary diagnostic laboratories or reference laboratories offering antimicrobial susceptibility testing services. This can result in delayed or inadequate testing, leading to suboptimal treatment decisions and compromised patient care. The limited accessibility to testing services can be a significant restraint for the market, particularly in areas with a high prevalence of antimicrobial resistance.

This Global Veterinary Antimicrobial Susceptibility testing Market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Global Veterinary Antimicrobial Susceptibility testing Market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In August 2022, BD a leading global medical technology company, and Accelerate Diagnostics, Inc. an innovator of rapid in-vitro diagnostics in microbiology, announced a worldwide commercial collaboration agreement where BD will offer Accelerate's rapid testing solution for antibiotic resistance and susceptibility offering results in hours, versus one to two days with some traditional laboratory methods
• In March 2021, F. Hoffmann-La Roche Ltd announced that it has entered into a collaboration with Eli Lilly and Company to support the development of Roche’s Elecsys Amyloid Plasma Panel (EAPP). The EAPP is an innovative blood test that aims to facilitate the earlier diagnosis of Alzheimer’s disease.

Global Veterinary Antimicrobial Susceptibility Testing Market Scope

The global veterinary antimicrobial susceptibility testing market is segmented on the basis of product type, animal type and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Disks and Plates
• Culture Media
• Accessories and Consumables
• Automated Antimicrobial Susceptibility Testing Instruments

Animal Type

• Food-producing Animals
• Companion Animals

End User

• Veterinary Reference Laboratory,
• Veterinary Research Institutes
• Universities

Global Veterinary Antimicrobial Susceptibility Testing Market Regional Analysis/Insights

The global veterinary antimicrobial susceptibility testing market is analysed and market size insights and trends are provided by product type, animal type and end user as referenced above.

The countries covered in the global veterinary antimicrobial susceptibility testing market report are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.

North America dominates the global veterinary antimicrobial susceptibility testing market because of North America has a well-developed and advanced healthcare infrastructure, including veterinary healthcare. The region boasts a comprehensive network of veterinary clinics, diagnostic laboratories, and research institutions that have the necessary resources and capabilities to perform antimicrobial susceptibility testing.   

Asia-Pacific is expected to witness significant growth during the forecast period of 2023 to 2030 as Asia Pacific region has a large and growing population with an increasing demand for animal protein, including meat, milk, and eggs. The intensification of animal production systems and the higher density of livestock can contribute to the spread of infectious diseases and antimicrobial resistance. As a result, there is a growing need for effective diagnostics, including antimicrobial susceptibility testing, to ensure the health and productivity of livestock and aquaculture.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The global veterinary antimicrobial susceptibility testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for the market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2010-2020.

Competitive Landscape and Global Veterinary Antimicrobial Susceptibility Testing Market Share Analysis

The global veterinary antimicrobial susceptibility testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to the market.

Some of the major players operating in the global veterinary antimicrobial susceptibility testing market are:

• BD (U.S.)
• Synbiosis (U.S.) 
• Zhuhai DL Biotech Co., Ltd. (China)
• Mast Group Ltd. (U.K.)
• HiMedia Laboratories (India)
• Thermo Fisher Scientific Inc. (U.S.)
• Bio-Rad Laboratories, Inc. (U.S.)
• Creative Diagnostics (U.S.)
• Genefluidics, Inc. (U.S.)
• Rosco Diagnostica A/S (Germany)
• ERBA Group (U.S.)
• Liofilchem S.r.l. (Italy)
• Alifax S.r.l. (Italy)
• MERLIN Gesellschaft für mikrobiologische Diagnostika mbH (Germany)
• bioMérieux SA (France)
• Merck KGaA. (U.S.)
• Danaher. (U.S.)
• Accelerate Diagnostics, Inc. (U.S.)
• NuMedii, Inc. (U.S.)
• BacterioScan, Inc. (U.S.)